• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

CIDRAP - As Asian hot spots battle Omicron, US eyes supply of 4th vaccine doses

Shiloh

Editor, Senior Moderator
Source: https://www.cidrap.umn.edu/news-per...ttle-omicron-us-eyes-supply-4th-vaccine-doses

As Asian hot spots battle Omicron, US eyes supply of 4th vaccine doses
Filed Under:
COVID-19
Lisa Schnirring | News Editor | CIDRAP News
| Mar 22, 2022


A handful of Asian countries that were hit later by Omicron variant surges are in different phases of their outbreaks, with South Korea seeing a possible peak.
In US developments, White House officials—bracing for a possible fresh spike in infections—warned that current funding shortfalls could block the government from buying enough COVID-19 vaccine for fourth doses for the general population.

High cases in Korea, Vietnam, Hong Kong

Two days ago, South Korea's daily cases dipped below 300,000 for the first time in 10 days, raising hopes among health officials that the country might be nearing its peak, which is expected between Mar 25 and Apr 1, according to the Korea Herald.
Today the country topped 300,000 cases again, as it started the process of gradually easing restrictions, such as raising the limit for private gatherings from six to eight. Also, officials are watching if the BA.2 subvariant, which makes up 26.3% of South Korea's sequenced samples, will raise COVID levels.
Elsewhere, China's ongoing surge continues with the highest levels in more than 2 years. Today the country reported 4,594 new local cases, which includes 2,313 symptomatic infections. The hardest-hit area for cases continues to be Jilin Province, where most infections are in Changchun and Jilin City.
Roughly a fourth of the asymptomatic cases are from Shanghai, where health officials are pressing on with block-by-block mass testing in an effort to detect and reduce the spread of the virus.
Meanwhile, cases in Hong Kong appear to be declining from record daily levels in the first week of March, with 14,152 cases reported today, as Vietnam is still reporting cases at very high levels, with 131,709 more yesterday.

Not enough funds for 4th US doses

Without Congress passing a $15 billion COVID funding package, White House officials said the federal government would not have enough funds to buy fourth COVID-19 booster doses for every American who wanted one.
While officials told the Washington Post that the Biden administration has the funds to purchase boosters for adults ages 65 and older and initial vaccine series for children 5 and younger—if approved—they currently cannot buy fourth booster doses for the general population.
The Centers for Disease Control COVID Data Tracker shows that 65.4% of Americans are fully vaccinated against COVID-19, 76.8% have received at least one dose of vaccine, and 44.5% of fully vaccinated Americans have received a booster dose.
COVID-19 cases in the United States continue to be significantly lower than during the Omicron surge. The nation reported 44,101 new COVID-19 cases yesterday and 1,472 deaths, according to the Johns Hopkins COVID-19 tracker.
The 7-day average of new daily cases is 29,612, with 1,056 daily deaths, according to the New York Times tracker.
Pediatric COVID-19 cases are also on the decline: According to the latest update from the American Academy of Pediatrics, 32,000 child COVID-19 cases were reported for the week ending Mar 17. Children represent 18.3% of new US cases.
CIDRAP News Reporter Stephanie Soucheray contributed to this story.
 
Back
Top Bottom